Discount Generic Prescription Study
The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs.
The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-income populations in Houston utilize the $4 for a 30-day supply or $10 for a 90-day supply, Generic Prescriptions Program offered by Kroger, Randalls, Target, Walmart, HEB, CVS, and Walgreens.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Discount Generic Prescription Utilization in Low-income Populations|
- Number of low-income adults who are aware of discount generic prescription programs (Survey) [ Time Frame: 12 Months (estimated survey completion time 20 minutes) ] [ Designated as safety issue: No ]
|Study Start Date:||August 2009|
|Study Completion Date:||May 2011|
|Primary Completion Date:||May 2011 (Final data collection date for primary outcome measure)|
20 minute survey to determine the relationship between awareness of the discount generic prescription program and utilization of the program.
Other Name: QuestionnaireBehavioral: Focus Group
5 - 8 focus groups of 6 - 10 people, lasting approximately 90 minutes
If you agree to take part in this study, you will take part in a focus group. The focus group will consist of about 8 people who will discuss beliefs about generic medication, awareness of discount generic prescription programs, and use of the discount generic prescription program. The focus group will last about 90 minutes.
During the focus group, you will complete a form that asks for basic demographic information (such as your age and sex).
The focus group discussions will be taped, and the recorded tapes will be transcribed word-for-word. The taped recording of the focus group study will be stored in a safe and secured locker by the study chair. The taped recordings will be destroyed after 5 years.
Length of Study:
Your participation on this study will end once you complete the focus group.
This is an investigational study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00971022
|United States, Texas|
|Houston, Texas, United States, 77036|
|Independence Heights Community Health Center|
|Houston, Texas, United States, 77018|
|Second Mile Mission Center|
|Houston, Texas, United States, 77477|
|Study Chair:||Lovell A. Jones, PHD, BS, MA||UT MD Anderson Cancer Center|
|Principal Investigator:||Anthony Omojasola, DRPH||UT MD Anderson Cancer Center|